Expert Witness in USP 800 Compliant Pharmacy Construction
Empire Projects, Inc., through its principal William N. Bernstein, AIA, has provided expert witness services in matters involving the construction, renovation, and project management of USP <800> compliant pharmacy facilities and hazardous drug compounding facilities, including hospital oncology compounding suites, ambulatory infusion center hazardous drug compounding rooms, 503A pharmacy hazardous drug compounding facilities, 503B outsourcing facility hazardous drug suites, and other hazardous drug handling facilities subject to USP <800>. Attorneys litigating cases that involve the construction, renovation, or project management of these facilities will need an expert witness such as William N. Bernstein, AIA, to address: construction defects, scheduling and delay claims, change order disputes, contractor and subcontractor performance issues, project management failures, cost overruns and budget disputes, payment disputes and mechanic’s liens, contract administration and interpretation, means and methods, construction safety, hazardous drug receiving and unpacking area construction defects (which must be negative pressure), containment SCA (C-SCA) construction failures, negative-pressure containment buffer room construction failures, externally vented PEC integration installation problems (Class II Type B2 BSCs, CACIs), failures to achieve and maintain required negative pressure differentials, HEPA filtration and exhaust installation failures including non-compliant routing of exhaust to safe locations, gowning and anteroom layout construction defects, hazardous drug storage and segregation construction failures, surface and joint installation defects affecting cleanability and decontamination, spill-response and containment construction failures, accessibility violations, fire safety and egress, water infiltration and building envelope failures, phased-construction disputes, and other claims related to USP <800> compliant pharmacy construction. Mr. Bernstein is an expert witness who understands both the applicable codes, standards, and contractual frameworks and the practical realities of how USP <800> compliant pharmacy construction and renovation projects are managed and executed in the field.
About USP 800 Compliant Pharmacy Construction
USP <800> compliant pharmacy construction and renovation encompasses hazardous drug handling and compounding facilities, including hospital oncology compounding suites, ambulatory infusion center hazardous drug compounding rooms, 503A pharmacy hazardous drug compounding facilities, 503B outsourcing facility hazardous drug suites, veterinary hazardous drug compounding facilities, and the support spaces that serve them, including hazardous drug receiving and unpacking areas (negative relative to ambient), hazardous drug storage areas, containment segregated compounding areas (C-SCAs), containment buffer rooms (ISO 7, negative pressure relative to the anteroom), externally vented primary engineering controls (CSTDs, BSC Class II Type B2, CACIs), anterooms (ISO 7, positive relative to ambient but accounting for the negative containment buffer room), gowning rooms, and spill-response stations. USP <800> compliant pharmacy construction is unusually demanding because the entire scheme inverts the pressurization cascade of conventional sterile compounding (toward negative containment) and because external venting of PECs must be carefully constructed to safe exhaust locations.
The construction and renovation of USP <800> compliant pharmacies is governed by a complex framework of building codes, regulations, and industry standards, including the applicable building code (for example, in New York City, the New York City Building Code), the International Building Code, ICC A117.1, NFPA 101 Life Safety Code, NFPA 99 Health Care Facilities Code, ASHRAE 170, USP General Chapter <800> for handling hazardous drugs in healthcare settings (which prescribes containment requirements, pressurization, PEC selection, external venting, and surface and material requirements), USP General Chapter <797> where the facility also performs sterile hazardous drug compounding, NIOSH hazardous drug list, ISO 14644 cleanroom classification standards, OSHA Hazardous Drugs requirements, state board of pharmacy regulations including state-level adoption of USP <800>, ADA requirements, and state and local department of health requirements. In addition, USP <800> compliant pharmacy construction projects are governed by private agreements — leases and work-letters where applicable, the prime contract and subcontracts, equipment vendor installation requirements, third-party certification agreements, and institutional procurement and approval procedures. These projects are also typically subject to insurance requirements, indemnification obligations, and bonding requirements that materially affect how risk is allocated and how disputes are resolved.
Disputes in USP <800> compliant pharmacy construction commonly arise over scheduling and delay claims, particularly when third-party cleanroom certification fails or environmental wipe-sampling detects hazardous drug contamination; change order disputes driven by board of pharmacy review, certification or wipe-sampling failures, late-discovered field conditions, and owner-directed scope changes; cost overruns and budget disputes; payment disputes and mechanic’s liens; contractor and subcontractor performance and coordination failures, particularly among HVAC, exhaust, controls, electrical, low-voltage, plumbing, casework, cleanroom-panel, and door/window trades whose work must achieve cleanroom-grade tolerances and maintain a negative-pressure cascade; hazardous drug receiving and unpacking area construction defects; C-SCA construction failures including non-compliant negative pressure, air-change rates, and external venting; containment buffer room failures to maintain required negative pressure differentials relative to surrounding spaces; externally vented PEC installation problems (failure to properly install and connect Class II Type B2 BSCs or CACIs for sterile hazardous drug compounding); HEPA filtration and exhaust installation defects including non-compliant routing of exhaust to safe locations; gowning and anteroom layout construction problems that compromise the containment scheme; hazardous drug storage and segregation construction failures; surface materials and joint installation defects affecting cleanability and decontamination; spill-response and containment construction failures; accessibility and fire-safety construction defects; building envelope and water-infiltration failures; and disputes arising from phased construction. Responsibility for these issues is allocated, in different ways, among the pharmacy operator, the landlord (where applicable), the contractor, subcontractors and specialty vendors, the construction manager or owner’s representative, the design professional, the certifying party, the board of pharmacy, and the party responsible for ongoing maintenance, and litigation in this area frequently turns on the allocation of responsibility for construction means and methods, sequencing, supervision, quality control, equipment coordination, commissioning, certification, and post-occupancy maintenance.
Expert Witness Services Related to USP 800 Compliant Pharmacy Construction
Expert witness services in USP <800> compliant pharmacy construction matters typically include a careful review of the project documents (drawings, specifications, submittals, RFIs, change orders, schedules and schedule updates, daily reports, meeting minutes, pay applications, lien waivers, permits, certificates of occupancy, cleanroom certification reports, hazardous drug wipe-sampling and environmental monitoring records, HEPA and exhaust certification reports, PEC certification reports, HVAC validation documentation, board of pharmacy filings, commissioning reports, punch lists, and as-built conditions), a site survey to measure and document the conditions at issue, comparison of those conditions against the applicable building codes, life safety codes, healthcare facility guidelines, accessibility standards, contract documents, and industry standards of care for construction and project management, review of construction administration records and maintenance histories, and the preparation of clear, well-supported opinions regarding causation, responsibility, the standard of care applicable to USP <800> compliant pharmacy construction, and the quantification of delay, disruption, and damages.
An effective USP <800> compliant pharmacy construction expert witness must be able to explain technical and project-management issues — construction sequencing and scheduling, change order management, contract interpretation (including AIA-form contracts and ConsensusDocs), construction means and methods, USP <800> containment philosophy and the negative-pressure cascade, hazardous drug receiving and storage area construction, C-SCA construction and limitations, containment buffer room construction with required negative pressure, primary engineering control installation (Class II Type B2 BSCs, CACIs) and external venting, HEPA filtration and exhaust installation and routing, gowning and anteroom construction under USP <800>, surface and material installation, spill-response construction, fire-rated assembly construction, egress geometry, accessibility installation, construction safety, code compliance, commissioning and certification, and the allocation of responsibility among owner, contractor, subcontractors, construction manager, design professionals, certifying parties, and specialty vendors — in plain language to judges, juries, arbitrators, and mediators, and must have the credentials, written record, and courtroom-ready communication skills to render credible opinions.
Mr. Bernstein is a Yale-trained, NCARB-certified, LEED-accredited, registered architect. He has expertise in architectural design, engineering design, and construction as the founder/owner of a construction project management firm, Empire Projects, Inc. (2003-Present), and as the founder/owner of an architectural firm, Bernstein & Associates, Architects (1990-present). He has been the expert witness (as of May 2026) on (40) cases involving design and construction (2006-present) across the United States and Internationally.
Contact
Please contact Empire Projects, Inc., for expert witness services related to USP <800> compliant pharmacy construction.